Amanda Spratt
Family · Spring, TXNPI 1043671779
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 25.3% of the total.
Across 79 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$455
- Lilly USA, LLC$227
- Dexcom, Inc.$182
- Medtronic$159
- QOL Medical, LLC$142
- AstraZeneca$127
- plus $507 from 16 others
What the payments were for
- Food & beverage$1,798100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $455 |
| Lilly USA, LLC | 15 | $227 |
| Dexcom, Inc. | 3 | $182 |
| Medtronic | 1 | $159 |
| QOL Medical, LLC | 1 | $142 |
| AstraZeneca | 8 | $127 |
| Pfizer | 4 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $76 |
| GSK | 2 | $38 |
| Amgen | 2 | $38 |
| Novartis | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Boehringer Ingelheim | 2 | $27 |
| Bayer | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| Abbott | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
| Exact Sciences | 1 | $15 |
| AbbVie | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$159
- DEXCOM G7 GSS (161)$142
- Sucraid$142
- Wegovy$101
How this compares
$1,798 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 42 | $756 |
| Levothyroxine Sodium | 42 | $460 |
| Fluticasone Propionate | 29 | $430 |
| Tamsulosin Hcl | 21 | $348 |
| Sertraline Hcl | 19 | $337 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $328 |
| Ondansetron OdtOndansetron | 27 | $317 |
| Bupropion XlBupropion Hcl | 11 | $288 |
| Rosuvastatin Calcium | 27 | $251 |
| Trazodone Hcl | 27 | $249 |
| Montelukast Sodium | 20 | $248 |
| Escitalopram Oxalate | 15 | $204 |
| Gabapentin | 14 | $198 |
| Amlodipine Besylate | 26 | $190 |
| Hydrochlorothiazide | 25 | $188 |
Paid to pharmacies, not to this prescriber.
Other family in Spring
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.